Source comparison
Men 45-55 Andropause Tesamorelin Protocol: Clinical vs Compounded Comparison
Regulatory Status FDA-approved for HIV-associated lipodystrophy; off-label for andropause Prepared by 503B outsourcing facilities or state-licensed compounding pharmacies. Not FDA-approved as a finished product Compounded versions use the same active molecule
This comparison does not assign a generated winner or score.
- Regulatory Status
- FDA-approved for HIV-associated lipodystrophy; off-label for andropause
- Prepared by 503B outsourcing facilities or state-licensed compounding pharmacies. Not FDA-approved as a finished product
- Compounded versions use the same active molecule but lack batch-level FDA oversight
- Cost per Month
- $2,800–$3,200 without insurance
- $250–$450 depending on source
- Compounded tesamorelin is 85-90% less expensive and functionally equivalent for research purposes
- Dosing Precision
- Pre-measured 2mg per vial, requires reconstitution
- Typically 2mg or 5mg per vial, user measures dose
- Both require reconstitution and dosing accuracy. Functional difference is minimal
- Purity Verification
- Batch testing with third-party verification per FDA standards
- Varies by supplier. Reputable 503B facilities provide certificates of analysis
- Choose suppliers offering third-party HPLC testing to confirm peptide purity
- Prescription Requirement
- Requires prescription from licensed physician
- Requires prescription; some telemedicine platforms facilitate access
- Both pathways are prescription-only. No legal over-the-counter tesamorelin exists
- Availability
- Limited by insurance coverage and prior authorization requirements
- Widely available through peptide suppliers and compounding pharmacies
- Compounded access is easier for men using protocols outside FDA-approved indications